The drug company Schering-Plough struggled globally because:
A) The global matrix structure was overly bureaucratic.
B) The integrating mechanisms used were too simple.
C) The multidomestic strategy led to duplication of activities.
D) FDA regulations hampered competition in the industry.

Question

Quizplus · Accepted Answer

Schering-Plough's multidomestic strategy led to duplication of activities, as each country had its own business unit, resulting in inefficiencies and increased costs. This hindered the company's global success.

The Drug Company Schering-Plough Struggled Globally Because